A method for detecting activated protein C (APC)-resistant factor V, especi
ally factor V Leiden, is described, which uses reagents containing two unfr
actionated snake venoms. The procedure can be used for testing plasma sampl
es from patients receiving oral anticoagulant therapy, heparin therapy and
patients with lupus anticoagulant, and does not require the use of factor-V
-deficient plasma. The sample plasma is first incubated with dilute venom f
rom Agkistrodon contortrix contortrix (Southern Copperhead) which activates
the endogenous protein C and then a dilute Russell's viper venom time test
is performed. In individuals with APC-resistant factor V, especially facto
r V Leiden, a marginal prolongation of dilute Russell's viper venom time wa
s noted [1.14 +/- 0.14 s (n = 16)]. Non-carriers were ea:lily discriminated
in each patient group, with a prolongation of 2.69 +/- 0.30 s for normal b
lood donors (n = 127), 2.61 +/- 0.38 s for patients taking oral anticoagula
nts (n = 102), 2.41 +/- 0.45 s for patients taking heparin (n = 96), and 2.
38 +/- 0.41 s for patients with lupus anticoagulant (n = 22). Patients taki
ng oral anticoagulants with moderate prolongation (between 1.5- and 2.0-fol
d) may have low levels of functional protein C and this might additionally
indicate a subgroup of such patients at higher than normal thrombotic risk.
Blood Coag Fibrinol 10:359-366 (C) 1999 Lippincott Williams & Wilkins.